APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Topical Anti-infective Drugs Market Analysis and Forecast 2026-2032

23 December 2025204 pages

Choose your research edition.

Industry ResearchTopical Anti-infective Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Anti-infective Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Topical Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Anti-infective Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Anti-infective Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Topical Anti-infective Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Topical Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Topical Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Topical Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Topical Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Topical Anti-infective Drugs include SK-SF, Zhejiang Funo Pharmaceuticals, Teva, Sun Pharmaceutical, Shandong Jingwei Pharmaceuticals, Sandoz, J & J, Liaoning Xingao Pharmaceuticals and Jiangsu Zhiyuan Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Topical Anti-infective Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Topical Anti-infective Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Topical Anti-infective Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Topical Anti-infective Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Topical Anti-infective Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Topical Anti-infective Drugs revenue, projected growth trends, production technology, application and end-user industry.

Topical Anti-infective Drugs Segment by Company

SK-SF

Zhejiang Funo Pharmaceuticals

Teva

Sun Pharmaceutical

Shandong Jingwei Pharmaceuticals

Sandoz

J & J

Liaoning Xingao Pharmaceuticals

Jiangsu Zhiyuan Pharmaceuticals

Jiangsu Fubang Pharmaceuticals

Hubei Renfu

Bayer

STADA Arzneimittel

LEO Pharma

Kaken Pharmaceutical

Haleon

Glenmark Pharmaceuticals

Galderma

Bausch Health

Almirall

Topical Anti-infective Drugs Segment by Type

Ointment

Solution

Gel

Other

Topical Anti-infective Drugs Segment by Application

Hospital

Retail Phamracy

Other

Topical Anti-infective Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Topical Anti-infective Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Topical Anti-infective Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Topical Anti-infective Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Topical Anti-infective Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ointment Major Player Table 3. Solution Major Player Table 4. Gel Major Player Table 5. Other Major Player Table 6. Global Topical Anti-infective Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Retail Phamracy Major Player Table 9. Other Major Player Table 10. Topical Anti-infective Drugs Industry Trends Table 11. Topical Anti-infective Drugs Industry Drivers Table 12. Topical Anti-infective Drugs Industry Opportunities and Challenges Table 13. Topical Anti-infective Drugs Industry Restraints Table 14. Global Topical Anti-infective Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Topical Anti-infective Drugs Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Topical Anti-infective Drugs Market Share by Region (2021-2026) Table 17. Global Topical Anti-infective Drugs Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Topical Anti-infective Drugs Market Share by Region (2027-2032) Table 19. Global Topical Anti-infective Drugs Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Topical Anti-infective Drugs Revenue Market Share by Players (2021-2026) Table 21. Global Topical Anti-infective Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Topical Anti-infective Drugs Key Players Headquarters & Area Served Table 23. Global Topical Anti-infective Drugs Players, Product Type & Application Table 24. Global Topical Anti-infective Drugs Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Topical Anti-infective Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Topical Anti-infective Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Topical Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Topical Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Topical Anti-infective Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Topical Anti-infective Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Topical Anti-infective Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Topical Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Topical Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Topical Anti-infective Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Topical Anti-infective Drugs Revenue Market Share by Application (2027-2032) Table 37. SK-SF Company Information Table 38. SK-SF Business Overview Table 39. SK-SF Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. SK-SF Topical Anti-infective Drugs Product Portfolio Table 41. SK-SF Recent Development Table 42. Zhejiang Funo Pharmaceuticals Company Information Table 43. Zhejiang Funo Pharmaceuticals Business Overview Table 44. Zhejiang Funo Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Zhejiang Funo Pharmaceuticals Topical Anti-infective Drugs Product Portfolio Table 46. Zhejiang Funo Pharmaceuticals Recent Development Table 47. Teva Company Information Table 48. Teva Business Overview Table 49. Teva Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Teva Topical Anti-infective Drugs Product Portfolio Table 51. Teva Recent Development Table 52. Sun Pharmaceutical Company Information Table 53. Sun Pharmaceutical Business Overview Table 54. Sun Pharmaceutical Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Sun Pharmaceutical Topical Anti-infective Drugs Product Portfolio Table 56. Sun Pharmaceutical Recent Development Table 57. Shandong Jingwei Pharmaceuticals Company Information Table 58. Shandong Jingwei Pharmaceuticals Business Overview Table 59. Shandong Jingwei Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Shandong Jingwei Pharmaceuticals Topical Anti-infective Drugs Product Portfolio Table 61. Shandong Jingwei Pharmaceuticals Recent Development Table 62. Sandoz Company Information Table 63. Sandoz Business Overview Table 64. Sandoz Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Sandoz Topical Anti-infective Drugs Product Portfolio Table 66. Sandoz Recent Development Table 67. J & J Company Information Table 68. J & J Business Overview Table 69. J & J Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. J & J Topical Anti-infective Drugs Product Portfolio Table 71. J & J Recent Development Table 72. Liaoning Xingao Pharmaceuticals Company Information Table 73. Liaoning Xingao Pharmaceuticals Business Overview Table 74. Liaoning Xingao Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Liaoning Xingao Pharmaceuticals Topical Anti-infective Drugs Product Portfolio Table 76. Liaoning Xingao Pharmaceuticals Recent Development Table 77. Jiangsu Zhiyuan Pharmaceuticals Company Information Table 78. Jiangsu Zhiyuan Pharmaceuticals Business Overview Table 79. Jiangsu Zhiyuan Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Jiangsu Zhiyuan Pharmaceuticals Topical Anti-infective Drugs Product Portfolio Table 81. Jiangsu Zhiyuan Pharmaceuticals Recent Development Table 82. Jiangsu Fubang Pharmaceuticals Company Information Table 83. Jiangsu Fubang Pharmaceuticals Business Overview Table 84. Jiangsu Fubang Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Jiangsu Fubang Pharmaceuticals Topical Anti-infective Drugs Product Portfolio Table 86. Jiangsu Fubang Pharmaceuticals Recent Development Table 87. Hubei Renfu Company Information Table 88. Hubei Renfu Business Overview Table 89. Hubei Renfu Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Hubei Renfu Topical Anti-infective Drugs Product Portfolio Table 91. Hubei Renfu Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Bayer Topical Anti-infective Drugs Product Portfolio Table 96. Bayer Recent Development Table 97. STADA Arzneimittel Company Information Table 98. STADA Arzneimittel Business Overview Table 99. STADA Arzneimittel Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. STADA Arzneimittel Topical Anti-infective Drugs Product Portfolio Table 101. STADA Arzneimittel Recent Development Table 102. LEO Pharma Company Information Table 103. LEO Pharma Business Overview Table 104. LEO Pharma Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. LEO Pharma Topical Anti-infective Drugs Product Portfolio Table 106. LEO Pharma Recent Development Table 107. Kaken Pharmaceutical Company Information Table 108. Kaken Pharmaceutical Business Overview Table 109. Kaken Pharmaceutical Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Kaken Pharmaceutical Topical Anti-infective Drugs Product Portfolio Table 111. Kaken Pharmaceutical Recent Development Table 112. Haleon Company Information Table 113. Haleon Business Overview Table 114. Haleon Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Haleon Topical Anti-infective Drugs Product Portfolio Table 116. Haleon Recent Development Table 117. Glenmark Pharmaceuticals Company Information Table 118. Glenmark Pharmaceuticals Business Overview Table 119. Glenmark Pharmaceuticals Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Glenmark Pharmaceuticals Topical Anti-infective Drugs Product Portfolio Table 121. Glenmark Pharmaceuticals Recent Development Table 122. Galderma Company Information Table 123. Galderma Business Overview Table 124. Galderma Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Galderma Topical Anti-infective Drugs Product Portfolio Table 126. Galderma Recent Development Table 127. Bausch Health Company Information Table 128. Bausch Health Business Overview Table 129. Bausch Health Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Bausch Health Topical Anti-infective Drugs Product Portfolio Table 131. Bausch Health Recent Development Table 132. Almirall Company Information Table 133. Almirall Business Overview Table 134. Almirall Topical Anti-infective Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Almirall Topical Anti-infective Drugs Product Portfolio Table 136. Almirall Recent Development Table 137. North America Topical Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Topical Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Topical Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Topical Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Topical Anti-infective Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Topical Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 143. North America Topical Anti-infective Drugs Revenue by Country (US$ Million) & (2027-2032) Table 144. Europe Topical Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Topical Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Topical Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Topical Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Topical Anti-infective Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Topical Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 150. Europe Topical Anti-infective Drugs Revenue by Country (US$ Million) & (2027-2032) Table 151. China Topical Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 152. China Topical Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 153. China Topical Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 154. China Topical Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Topical Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 156. Asia Topical Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 157. Asia Topical Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Topical Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Topical Anti-infective Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Topical Anti-infective Drugs Revenue by Region (US$ Million) & (2021-2026) Table 161. Asia Topical Anti-infective Drugs Revenue by Region (US$ Million) & (2027-2032) Table 162. SAMEA Topical Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Topical Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Topical Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Topical Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Topical Anti-infective Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Topical Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 168. SAMEA Topical Anti-infective Drugs Revenue by Country (US$ Million) & (2027-2032) Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Topical Anti-infective Drugs Image Figure 2. Global Topical Anti-infective Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Anti-infective Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ointment Image Figure 5. Solution Image Figure 6. Gel Image Figure 7. Other Image Figure 8. Global Topical Anti-infective Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Topical Anti-infective Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Phamracy Image Figure 12. Other Image Figure 13. Global Topical Anti-infective Drugs Market Size (US$ Million) & (2021-2032) Figure 14. Global Topical Anti-infective Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Topical Anti-infective Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Topical Anti-infective Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Topical Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Topical Anti-infective Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Topical Anti-infective Drugs Revenue Market Share by Type (2021-2032) Figure 21. Global Topical Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Topical Anti-infective Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Topical Anti-infective Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Topical Anti-infective Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Topical Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 26. North America Topical Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 27. North America Topical Anti-infective Drugs Revenue Share by Country (2021-2032) Figure 28. United States Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Topical Anti-infective Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Topical Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 33. Europe Topical Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 34. Europe Topical Anti-infective Drugs Revenue Share by Country (2021-2032) Figure 35. Germany Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Topical Anti-infective Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Topical Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 45. China Topical Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 46. Asia Topical Anti-infective Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Topical Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 48. Asia Topical Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 49. Asia Topical Anti-infective Drugs Revenue Share by Region (2021-2032) Figure 50. Japan Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Topical Anti-infective Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Topical Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 58. SAMEA Topical Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 59. SAMEA Topical Anti-infective Drugs Revenue Share by Country (2021-2032) Figure 60. Brazil Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Topical Anti-infective Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ointment
  • Solution
  • Gel
  • Other
Applications
  • Hospital
  • Retail Phamracy
  • Other
Companies covered
  • SK-SF
  • Zhejiang Funo Pharmaceuticals
  • Teva
  • Sun Pharmaceutical
  • Shandong Jingwei Pharmaceuticals
  • Sandoz
  • J & J
  • Liaoning Xingao Pharmaceuticals
  • Jiangsu Zhiyuan Pharmaceuticals
  • Jiangsu Fubang Pharmaceuticals
  • Hubei Renfu
  • Bayer
  • STADA Arzneimittel
  • LEO Pharma
  • Kaken Pharmaceutical
  • Haleon
  • Glenmark Pharmaceuticals
  • Galderma
  • Bausch Health
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Topical Anti-infective Drugs Market by Type
  3. 1.2.1 Global Topical Anti-infective Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ointment
  5. 1.2.3 Solution
  6. 1.2.4 Gel
  7. 1.2.5 Other
  8. 1.3 Topical Anti-infective Drugs Market by Application
  9. 1.3.1 Global Topical Anti-infective Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Phamracy
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Topical Anti-infective Drugs Market Dynamics
  1. 2.1 Topical Anti-infective Drugs Industry Trends
  2. 2.2 Topical Anti-infective Drugs Industry Drivers
  3. 2.3 Topical Anti-infective Drugs Industry Opportunities and Challenges
  4. 2.4 Topical Anti-infective Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Topical Anti-infective Drugs Market Perspective (2021-2032)
  2. 3.2 Global Topical Anti-infective Drugs Growth Trends by Region
  3. 3.2.1 Global Topical Anti-infective Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Topical Anti-infective Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Topical Anti-infective Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Topical Anti-infective Drugs Revenue by Players
  2. 4.1.1 Global Topical Anti-infective Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Topical Anti-infective Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Topical Anti-infective Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Topical Anti-infective Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Topical Anti-infective Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Topical Anti-infective Drugs Players, Product Type & Application
  8. 4.5 Global Topical Anti-infective Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Topical Anti-infective Drugs Market CR5 and HHI
  11. 4.6.3 2025 Topical Anti-infective Drugs Tier 1, Tier 2, and Tier 3
5 Topical Anti-infective Drugs Market Size by Type
  1. 5.1 Global Topical Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Topical Anti-infective Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Topical Anti-infective Drugs Revenue Market Share by Type (2021-2032)
6 Topical Anti-infective Drugs Market Size by Application
  1. 6.1 Global Topical Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Topical Anti-infective Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Topical Anti-infective Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SK-SF
  2. 7.1.1 SK-SF Company Information
  3. 7.1.2 SK-SF Business Overview
  4. 7.1.3 SK-SF Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SK-SF Topical Anti-infective Drugs Product Portfolio
  6. 7.1.5 SK-SF Recent Developments
  7. 7.2 Zhejiang Funo Pharmaceuticals
  8. 7.2.1 Zhejiang Funo Pharmaceuticals Company Information
  9. 7.2.2 Zhejiang Funo Pharmaceuticals Business Overview
  10. 7.2.3 Zhejiang Funo Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zhejiang Funo Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
  12. 7.2.5 Zhejiang Funo Pharmaceuticals Recent Developments
  13. 7.3 Teva
  14. 7.3.1 Teva Company Information
  15. 7.3.2 Teva Business Overview
  16. 7.3.3 Teva Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Teva Topical Anti-infective Drugs Product Portfolio
  18. 7.3.5 Teva Recent Developments
  19. 7.4 Sun Pharmaceutical
  20. 7.4.1 Sun Pharmaceutical Company Information
  21. 7.4.2 Sun Pharmaceutical Business Overview
  22. 7.4.3 Sun Pharmaceutical Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sun Pharmaceutical Topical Anti-infective Drugs Product Portfolio
  24. 7.4.5 Sun Pharmaceutical Recent Developments
  25. 7.5 Shandong Jingwei Pharmaceuticals
  26. 7.5.1 Shandong Jingwei Pharmaceuticals Company Information
  27. 7.5.2 Shandong Jingwei Pharmaceuticals Business Overview
  28. 7.5.3 Shandong Jingwei Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shandong Jingwei Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
  30. 7.5.5 Shandong Jingwei Pharmaceuticals Recent Developments
  31. 7.6 Sandoz
  32. 7.6.1 Sandoz Company Information
  33. 7.6.2 Sandoz Business Overview
  34. 7.6.3 Sandoz Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz Topical Anti-infective Drugs Product Portfolio
  36. 7.6.5 Sandoz Recent Developments
  37. 7.7 J & J
  38. 7.7.1 J & J Company Information
  39. 7.7.2 J & J Business Overview
  40. 7.7.3 J & J Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 J & J Topical Anti-infective Drugs Product Portfolio
  42. 7.7.5 J & J Recent Developments
  43. 7.8 Liaoning Xingao Pharmaceuticals
  44. 7.8.1 Liaoning Xingao Pharmaceuticals Company Information
  45. 7.8.2 Liaoning Xingao Pharmaceuticals Business Overview
  46. 7.8.3 Liaoning Xingao Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Liaoning Xingao Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
  48. 7.8.5 Liaoning Xingao Pharmaceuticals Recent Developments
  49. 7.9 Jiangsu Zhiyuan Pharmaceuticals
  50. 7.9.1 Jiangsu Zhiyuan Pharmaceuticals Company Information
  51. 7.9.2 Jiangsu Zhiyuan Pharmaceuticals Business Overview
  52. 7.9.3 Jiangsu Zhiyuan Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Jiangsu Zhiyuan Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
  54. 7.9.5 Jiangsu Zhiyuan Pharmaceuticals Recent Developments
  55. 7.10 Jiangsu Fubang Pharmaceuticals
  56. 7.10.1 Jiangsu Fubang Pharmaceuticals Company Information
  57. 7.10.2 Jiangsu Fubang Pharmaceuticals Business Overview
  58. 7.10.3 Jiangsu Fubang Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Jiangsu Fubang Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
  60. 7.10.5 Jiangsu Fubang Pharmaceuticals Recent Developments
  61. 7.11 Hubei Renfu
  62. 7.11.1 Hubei Renfu Company Information
  63. 7.11.2 Hubei Renfu Business Overview
  64. 7.11.3 Hubei Renfu Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Hubei Renfu Topical Anti-infective Drugs Product Portfolio
  66. 7.11.5 Hubei Renfu Recent Developments
  67. 7.12 Bayer
  68. 7.12.1 Bayer Company Information
  69. 7.12.2 Bayer Business Overview
  70. 7.12.3 Bayer Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bayer Topical Anti-infective Drugs Product Portfolio
  72. 7.12.5 Bayer Recent Developments
  73. 7.13 STADA Arzneimittel
  74. 7.13.1 STADA Arzneimittel Company Information
  75. 7.13.2 STADA Arzneimittel Business Overview
  76. 7.13.3 STADA Arzneimittel Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  77. 7.13.4 STADA Arzneimittel Topical Anti-infective Drugs Product Portfolio
  78. 7.13.5 STADA Arzneimittel Recent Developments
  79. 7.14 LEO Pharma
  80. 7.14.1 LEO Pharma Company Information
  81. 7.14.2 LEO Pharma Business Overview
  82. 7.14.3 LEO Pharma Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  83. 7.14.4 LEO Pharma Topical Anti-infective Drugs Product Portfolio
  84. 7.14.5 LEO Pharma Recent Developments
  85. 7.15 Kaken Pharmaceutical
  86. 7.15.1 Kaken Pharmaceutical Company Information
  87. 7.15.2 Kaken Pharmaceutical Business Overview
  88. 7.15.3 Kaken Pharmaceutical Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Kaken Pharmaceutical Topical Anti-infective Drugs Product Portfolio
  90. 7.15.5 Kaken Pharmaceutical Recent Developments
  91. 7.16 Haleon
  92. 7.16.1 Haleon Company Information
  93. 7.16.2 Haleon Business Overview
  94. 7.16.3 Haleon Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Haleon Topical Anti-infective Drugs Product Portfolio
  96. 7.16.5 Haleon Recent Developments
  97. 7.17 Glenmark Pharmaceuticals
  98. 7.17.1 Glenmark Pharmaceuticals Company Information
  99. 7.17.2 Glenmark Pharmaceuticals Business Overview
  100. 7.17.3 Glenmark Pharmaceuticals Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Glenmark Pharmaceuticals Topical Anti-infective Drugs Product Portfolio
  102. 7.17.5 Glenmark Pharmaceuticals Recent Developments
  103. 7.18 Galderma
  104. 7.18.1 Galderma Company Information
  105. 7.18.2 Galderma Business Overview
  106. 7.18.3 Galderma Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Galderma Topical Anti-infective Drugs Product Portfolio
  108. 7.18.5 Galderma Recent Developments
  109. 7.19 Bausch Health
  110. 7.19.1 Bausch Health Company Information
  111. 7.19.2 Bausch Health Business Overview
  112. 7.19.3 Bausch Health Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Bausch Health Topical Anti-infective Drugs Product Portfolio
  114. 7.19.5 Bausch Health Recent Developments
  115. 7.20 Almirall
  116. 7.20.1 Almirall Company Information
  117. 7.20.2 Almirall Business Overview
  118. 7.20.3 Almirall Topical Anti-infective Drugs Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Almirall Topical Anti-infective Drugs Product Portfolio
  120. 7.20.5 Almirall Recent Developments
8 North America
  1. 8.1 North America Topical Anti-infective Drugs Revenue (2021-2032)
  2. 8.2 North America Topical Anti-infective Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Topical Anti-infective Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Topical Anti-infective Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Topical Anti-infective Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Topical Anti-infective Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Topical Anti-infective Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Topical Anti-infective Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Topical Anti-infective Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Topical Anti-infective Drugs Revenue by Country
  11. 8.6.1 North America Topical Anti-infective Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Topical Anti-infective Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Topical Anti-infective Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Topical Anti-infective Drugs Revenue (2021-2032)
  2. 9.2 Europe Topical Anti-infective Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Topical Anti-infective Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Topical Anti-infective Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Topical Anti-infective Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Topical Anti-infective Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Topical Anti-infective Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Topical Anti-infective Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Topical Anti-infective Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Topical Anti-infective Drugs Revenue by Country
  11. 9.6.1 Europe Topical Anti-infective Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Topical Anti-infective Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Topical Anti-infective Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Topical Anti-infective Drugs Revenue (2021-2032)
  2. 10.2 China Topical Anti-infective Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Topical Anti-infective Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Topical Anti-infective Drugs Revenue by Type (2027-2032)
  5. 10.3 China Topical Anti-infective Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Topical Anti-infective Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Topical Anti-infective Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Topical Anti-infective Drugs Revenue by Application (2027-2032)
  9. 10.5 China Topical Anti-infective Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Topical Anti-infective Drugs Revenue (2021-2032)
  2. 11.2 Asia Topical Anti-infective Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Topical Anti-infective Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Topical Anti-infective Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Topical Anti-infective Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Topical Anti-infective Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Topical Anti-infective Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Topical Anti-infective Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Topical Anti-infective Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Topical Anti-infective Drugs Revenue by Country
  11. 11.6.1 Asia Topical Anti-infective Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Topical Anti-infective Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Topical Anti-infective Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Topical Anti-infective Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Topical Anti-infective Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Topical Anti-infective Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Topical Anti-infective Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Topical Anti-infective Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Topical Anti-infective Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Topical Anti-infective Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Topical Anti-infective Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Topical Anti-infective Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Topical Anti-infective Drugs Revenue by Country
  11. 12.6.1 SAMEA Topical Anti-infective Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Topical Anti-infective Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Topical Anti-infective Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst